Camizestrant

ATC L02BA05 · 3 markets · 3 records

Camizestrant 3 markets · 3 records Forms

Filters

MarketUS 1 CA 1 EU 1

Strength

US 1 records · 1 shown of 1 Source openFDA NDC Directory · Data as of 2026-10-23

75 mgtabletETCAMAH also in CA

CA 1 records · 1 shown of 1 Source Health Canada Drug Product Databas · Data as of 2026-10-23

75 mgtabletETCAMAH also in US

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名ETCAMAH ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

Side-by-side table

Strength / form / release	US	CA	EU
75 mg tablet	ETCAMAH	ETCAMAH	not recorded
not disclosed unknown	not recorded	not recorded	ETCAMAH

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

1 more strength/form rows are recorded only in EU and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en EU que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 EU 有记录（未在本表显示）。另有 1 個規格/劑型僅在 EU 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.